127 related articles for article (PubMed ID: 15188177)
1. Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease.
Drenth JP; Martina JA; Te Morsche RH; Jansen JB; Bonifacino JS
Gastroenterology; 2004 Jun; 126(7):1819-27. PubMed ID: 15188177
[TBL] [Abstract][Full Text] [Related]
2. Polycystic liver disease is a disorder of cotranslational protein processing.
Drenth JP; Martina JA; van de Kerkhof R; Bonifacino JS; Jansen JB
Trends Mol Med; 2005 Jan; 11(1):37-42. PubMed ID: 15649821
[TBL] [Abstract][Full Text] [Related]
3. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Waanders E; Croes HJ; Maass CN; te Morsche RH; van Geffen HJ; van Krieken JH; Fransen JA; Drenth JP
Histochem Cell Biol; 2008 Mar; 129(3):301-10. PubMed ID: 18224332
[TBL] [Abstract][Full Text] [Related]
4. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Li A; Davila S; Furu L; Qian Q; Tian X; Kamath PS; King BF; Torres VE; Somlo S
Am J Hum Genet; 2003 Mar; 72(3):691-703. PubMed ID: 12529853
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of hepatocystin induces autophagy through an mTOR-dependent pathway.
Yang J; Zhao Y; Ma K; Jiang FJ; Liao W; Zhang P; Zhou J; Tu B; Wang L; Kampinga HH; Xie Z; Zhu WG
Autophagy; 2011 Jul; 7(7):748-59. PubMed ID: 21681021
[TBL] [Abstract][Full Text] [Related]
7. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease].
Jansen JB; Morsche RH; Drenth JP
Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1408-12. PubMed ID: 12894465
[TBL] [Abstract][Full Text] [Related]
9. Hepatocystin is Essential for TRPM7 Function During Early Embryogenesis.
Overton JD; Komiya Y; Mezzacappa C; Nama K; Cai N; Lou L; Fedeles SV; Habas R; Runnels LW
Sci Rep; 2015 Dec; 5():18395. PubMed ID: 26671672
[TBL] [Abstract][Full Text] [Related]
10. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease.
Janssen MJ; Waanders E; Woudenberg J; Lefeber DJ; Drenth JP
J Hepatol; 2010 Mar; 52(3):432-40. PubMed ID: 20138683
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions.
Yoo JJ; Lee DH; Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
J Bioenerg Biomembr; 2016 Dec; 48(6):581-590. PubMed ID: 27640193
[TBL] [Abstract][Full Text] [Related]
12. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.
Drenth JP; te Morsche RH; Smink R; Bonifacino JS; Jansen JB
Nat Genet; 2003 Mar; 33(3):345-7. PubMed ID: 12577059
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.
Peces R; Drenth JP; Te Morsche RH; González P; Peces C
World J Gastroenterol; 2005 Dec; 11(48):7690-3. PubMed ID: 16437702
[TBL] [Abstract][Full Text] [Related]
15. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
[TBL] [Abstract][Full Text] [Related]
16. Hepatocystin contributes to interferon-mediated antiviral response to hepatitis B virus by regulating hepatocyte nuclear factor 4α.
Shin GC; Ahn SH; Choi HS; Kim J; Park ES; Kim DH; Kim KH
Biochim Biophys Acta; 2014 Sep; 1842(9):1648-57. PubMed ID: 24769044
[TBL] [Abstract][Full Text] [Related]
17. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.
Li YM; Mitsuhashi T; Wojciechowicz D; Shimizu N; Li J; Stitt A; He C; Banerjee D; Vlassara H
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11047-52. PubMed ID: 8855306
[TBL] [Abstract][Full Text] [Related]
18. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
19. Vacuolar system-associated protein-60: a protein characterized from bovine granulosa and luteal cells that is associated with intracellular vesicles and related to human 80K-H and murine beta-glucosidase II.
Brûlé S; Rabahi F; Faure R; Beckers JF; Silversides DW; Lussier JG
Biol Reprod; 2000 Mar; 62(3):642-54. PubMed ID: 10684806
[TBL] [Abstract][Full Text] [Related]
20. Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell.
Shin GC; Ahn SH; Choi HS; Lim KH; Choi DY; Kim KP; Kim KH
Biochim Biophys Acta; 2013 Oct; 1832(10):1569-81. PubMed ID: 23644164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
